Back to previous page

Seqirus to build £15m vaccine production facility in Liverpool

Flu vaccine provider Seqirus is to develop a £15.3m production facility at its manufacturing plant in Liverpool as part of a planned expansion of activity at the site.

Available to registered users only

Already registered?

If you are registered for newsletters you can already access stories for FREE, enter your details here

Customer Service: 08448 489 727, or email